Evidence map›Paper›PMID 24265932›Full record

ArticleEuropean journal of microbiology & immunology2013

Innate lymphoid cells in the defense against infections.

Andreas Diefenbach

Abstract read
In one paragraph

Article in European journal of microbiology & immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. IL-23 Contributes toFrontiers in immunology · 2020
    Article
  5. Review
  6. Review
  7. Journal of immunology research · 2019
    Article
  8. A Human LinFrontiers in immunology · 2017
    Article
  9. The Unresolved Role of Interferon-λ inFrontiers in immunology · 2017
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Andreas DiefenbachSection of Molecular Infection Biology, Department of Medical Microbiology and Hygiene, University of Freiburg Hermann-Herder-Strasse 11, D-79104 Freiburg Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Barrier surfaces are under constant attack by potentially dangerous microbes. Interestingly, mucosal tissues contain a large number of innate lymphocytes now collectively referred to as innate lymphoid cells (ILCs). Different groups of ILCs are being distinguished, each of which produce an array of cytokines strikingly resembling the profile of the various T helper cell effector subsets. Over the last couple of years, evidence has been emerging that the various ILC subsets play important roles in immune defense against mucosal infections. In this review, I will introduce the various groups of ILCs and then focus on their roles for immunity to mucosal infections.

Indexed as

CandidaHelicobacterinnate lymphoid cells (ILCs)natural killer (NK) cellsSalmonella

Identifiers

PMID24265932
PMCPMC3832102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.